Aligos Therapeutics (ALGS) Income Statement (2019 - 2026)
Income Statement report data from Sep 30, 2019 to Mar 31, 2026 for Aligos Therapeutics (ALGS).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Sep 30, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | ||||||||||||||||||||||||||
Total Revenue | 2.83M (+1564.71%) | 170K (-77.03%) | 740K (-23.71%) | 970K (+212.90%) | 310K (-49.18%) | 610K (-51.20%) | 1.25M (+17.92%) | 1.06M (+53.62%) | 690K (+2.99%) | 670K (-38.53%) | 1.09M (-74.59%) | 4.29M (+2964.29%) | 140K | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses | ||||||||||||||||||||||||||
Research And Development | 23M (+37.03%) | 17M (-28.82%) | 24M (+71.24%) | 14M (-3.59%) | 15M (-9.54%) | 16M (-4.41%) | 17M (-20.52%) | 21M (+28.89%) | 16M (-26.46%) | 22M (+40.26%) | 16M (-5.42%) | 17M (-7.50%) | 18M (-5.03%) | 19M (+7.36%) | 18M (+7.75%) | 17M (-47.89%) | 32M (+10.77%) | 29M (+1.67%) | 28M (+14.58%) | 25M (+7.35%) | 23M (-18.55%) | 28M (+62.03%) | 17M (+0.87%) | 17M (-0.69%) | 17M (+47.49%) | 12M |
Selling General And Administrative | 6.41M (+29.49%) | 4.95M (-4.26%) | 5.17M (-7.01%) | 5.56M (+10.10%) | 5.05M (-2.13%) | 5.16M (+11.45%) | 4.63M (-27.43%) | 6.38M (-4.35%) | 6.67M (+3.89%) | 6.42M (-0.31%) | 6.44M (-30.38%) | 9.25M (+8.70%) | 8.51M (+19.52%) | 7.12M (+35.36%) | 5.26M (-30.61%) | 7.58M (+17.52%) | 6.45M (-33.64%) | 9.72M (+50.23%) | 6.47M (-1.37%) | 6.56M (+13.49%) | 5.78M (-6.92%) | 6.21M (+47.16%) | 4.22M (+2.93%) | 4.10M (+19.88%) | 3.42M (+23.02%) | 2.78M |
Operating Expenses | 30M (+35.40%) | 22M (-24.47%) | 29M (+49.00%) | 20M (-0.10%) | 20M (-7.74%) | 21M (-0.98%) | 21M (-22.13%) | 27M (+19.32%) | 23M (-19.70%) | 29M (+28.55%) | 22M (-14.29%) | 26M (-2.29%) | 27M (+1.60%) | 26M (+13.75%) | 23M (-4.32%) | 24M (-36.82%) | 38M (-0.50%) | 38M (+10.75%) | 35M (+11.22%) | 31M (+8.59%) | 29M (-16.42%) | 34M (+59.00%) | 22M (+1.36%) | 21M (+2.65%) | 21M (+42.90%) | 15M |
Depreciation And Amortization | 350K (+45.83%) | 240K (+20.00%) | 200K (-33.33%) | 300K (+57.89%) | 190K (+35.71%) | 140K (-53.33%) | 300K (0.00%) | 300K (+7.14%) | 280K (-31.71%) | 410K (+36.67%) | 300K (-25.00%) | 400K (-11.11%) | 450K (-15.09%) | 530K (+6.00%) | 500K (-16.67%) | 600K (-11.76%) | 680K (0.00%) | 680K (-15.00%) | 800K (0.00%) | 800K (+8.11%) | 740K (-27.45%) | 1.02M (+43.66%) | 710K (+4.41%) | 680K (+106.06%) | 330K (-15.38%) | 390K |
Operating Income | ||||||||||||||||||||||||||
Operating Income | -26.93M (+23.48%) | -21.81M (-23.10%) | -28.36M (+52.72%) | -18.57M (-3.48%) | -19.24M (-6.42%) | -20.56M (+2.14%) | -20.13M (-23.78%) | -26.41M (+19.77%) | -22.05M (-15.19%) | -26.00M (+36.34%) | -19.07M (-0.37%) | -19.14M (-19.98%) | -23.92M (+5.47%) | -22.68M (+19.68%) | -18.95M (-7.06%) | -20.39M (-42.66%) | -35.56M (-6.30%) | -37.95M (+14.76%) | -33.07M (+11.87%) | -29.56M (+6.56%) | -27.74M (-19.08%) | -34.28M (+59.00%) | -21.56M (+1.36%) | -21.27M (+2.65%) | -20.72M (+42.90%) | -14.50M |
Ebit | -26.93M (+23.48%) | -21.81M (-23.10%) | -28.36M (+52.72%) | -18.57M (-3.48%) | -19.24M (-6.42%) | -20.56M (+2.14%) | -20.13M (-23.78%) | -26.41M (+19.77%) | -22.05M (-15.19%) | -26.00M (+36.34%) | -19.07M (-0.37%) | -19.14M (-19.98%) | -23.92M (+5.47%) | -22.68M (+19.68%) | -18.95M (-7.06%) | -20.39M (-42.66%) | -35.56M (-6.30%) | -37.95M (+14.76%) | -33.07M (+11.87%) | -29.56M (+6.56%) | -27.74M (-19.08%) | -34.28M (+59.00%) | -21.56M (+1.36%) | -21.27M (+2.65%) | -20.72M (+42.90%) | -14.50M |
EBITDA | -26.58M (+23.17%) | -21.58M (-23.37%) | -28.16M (+54.13%) | -18.27M (-4.09%) | -19.05M (-6.71%) | -20.42M (+2.98%) | -19.83M (-24.05%) | -26.11M (+19.99%) | -21.76M (-14.97%) | -25.59M (+36.33%) | -18.77M (+0.16%) | -18.74M (-20.12%) | -23.46M (+5.91%) | -22.15M (+20.05%) | -18.45M (-6.77%) | -19.79M (-43.26%) | -34.88M (-6.41%) | -37.27M (+15.49%) | -32.27M (+12.20%) | -28.76M (+6.52%) | -27.00M (-18.85%) | -33.27M (+59.57%) | -20.85M (+1.26%) | -20.59M (+0.98%) | -20.39M (+44.41%) | -14.12M |
Net Income | ||||||||||||||||||||||||||
Income Before Tax | -22.72M (+14.46%) | -19.85M (-36.94%) | -31.48M (+100.77%) | -15.68M | 43M | -82.12M (+328.38%) | -19.17M | 5.25M | -34.84M (+24.79%) | -27.92M (+55.02%) | -18.01M (-0.11%) | -18.03M (-21.34%) | -22.92M (+4.95%) | -21.84M (+17.04%) | -18.66M (-6.14%) | -19.88M (-44.09%) | -35.56M (-5.85%) | -37.77M (+14.45%) | -33.00M (+10.78%) | -29.79M (+7.82%) | -27.63M (-74.51%) | -108.38M | - | - | - | - |
Income Tax Expense | 320K (+966.67%) | 30K (-50.00%) | 60K (-68.42%) | 190K (+375.00%) | 40K (+33.33%) | 30K (-66.67%) | 90K (-52.63%) | 190K (+850.00%) | 20K | -30.00K | 30K (-96.05%) | 760K (+1800.00%) | 40K (-20.00%) | 50K | -40.00K | 50K (0.00%) | 50K | -60.00K | 130K (+333.33%) | 30K (-40.00%) | 50K (-77.27%) | 220K | - | -60.00K | - | - |
Net Income From Continuing Operations | -23.04M (+15.90%) | -19.88M (-36.97%) | -31.54M (+98.87%) | -15.86M | 43M | -82.15M (+326.53%) | -19.26M | 5.06M | -34.86M (+24.99%) | -27.89M (+54.60%) | -18.04M (-3.99%) | -18.79M (-18.13%) | -22.95M (+4.84%) | -21.89M (+17.56%) | -18.62M (-6.53%) | -19.92M (-44.06%) | -35.61M (-5.59%) | -37.72M (+13.89%) | -33.12M (+11.07%) | -29.82M (+7.77%) | -27.67M (-19.61%) | -34.42M (+3.36%) | -33.30M (+60.10%) | -20.80M (+3.84%) | -20.03M (+42.56%) | -14.05M |
Net Income | -23.04M (+15.90%) | -19.88M (-36.97%) | -31.54M (+98.87%) | -15.86M | 43M | -82.15M (+326.53%) | -19.26M | 5.06M | -34.86M (+24.99%) | -27.89M (+54.60%) | -18.04M (-3.99%) | -18.79M (-18.13%) | -22.95M (+4.84%) | -21.89M (+17.56%) | -18.62M (-6.53%) | -19.92M (-44.06%) | -35.61M (-5.59%) | -37.72M (+13.89%) | -33.12M (+11.07%) | -29.82M (+7.77%) | -27.67M (-19.61%) | -34.42M (+3.36%) | -33.30M (+60.10%) | -20.80M (+3.84%) | -20.03M (+42.56%) | -14.05M |
Comprehensive Income Net Of Tax | -23.07M (-4.59%) | -24.18M (-23.24%) | -31.50M (+98.24%) | -15.89M | 43M | -131.30M (+584.57%) | -19.18M | 5.08M | -34.93M (-60.09%) | -87.53M (+385.20%) | -18.04M (-3.99%) | -18.79M (-17.80%) | -22.86M (-76.21%) | -96.10M (+419.18%) | -18.51M (-7.82%) | -20.08M (-44.00%) | -35.86M (-71.92%) | -127.69M (+285.54%) | -33.12M (+10.99%) | -29.84M (+7.69%) | -27.71M (-74.49%) | -108.62M (+225.11%) | -33.41M (+58.34%) | -21.10M (+8.43%) | -19.46M (+38.11%) | -14.09M |